Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab. Revista Alergia México, [S. l.], v. 72, n. 3, p. 216, 2025. DOI: 10.29262/ram.v72i3.1490. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1490. Acesso em: 24 sep. 2026.